AMP/ASCO/CAP 2017 Aligned Profiles
The following profiles align with terminology and curation conventions from the 2017 AMP/ASCO/CAP Clinical Variant Interpretation Guidelines.
These initial profiles were developed to support the following implementations and use cases:
Implementer |
Use Case |
|---|---|
VICC MetaKB |
Using VA-Spec models to structure diagnostic, prognostic, and therapeutic response variant classifications and evidence in its community-facing data exchange APIs. |
ClinVar Submission Utility |
Uses VA-Spec as input format for submission tools that send variant classifications and evidence from CIViC to the ClinVar database via its API. |
The number and coverage of these profiles will grow as these implementations expand their scope, and additional adopters bring new use cases to the spec.
Variant Clinical Significance Statement (AAC 2017)
Draft
May change significantly in future releases. See Maturity Model.
Computational Definition
A statement reporting a conclusion from a single study about the clinical significance of a variant with respect to a condition, based on interpretation of the study’s results.
Information Model
Field |
Flags |
Type |
Limits |
Description |
|---|---|---|---|---|
id |
string |
0..1 |
The ‘logical’ identifier of the Entity in the system of record, e.g. a UUID. This ‘id’ is unique within a given system, but may or may not be globally unique outside the system. It is used within a system to reference an object from another. |
|
type |
string |
1..1 |
MUST be “Statement”. |
|
name |
string |
0..1 |
A primary name for the entity. |
|
description |
string |
0..1 |
A free-text description of the Entity. |
|
aliases |
⋮ | string |
0..m |
Alternative name(s) for the Entity. |
extensions |
⋮ | 0..m |
A list of extensions to the Entity, that allow for capture of information not directly supported by elements defined in the model. |
|
specifiedBy |
1..1 |
A specification that describes all or part of the process that led to creation of the Information Entity |
||
contributions |
↓ | 0..m |
Specific actions taken by an Agent toward the creation, modification, validation, or deprecation of an Information Entity. |
|
reportedIn |
⋮ | 0..m |
A document in which the the Information Entity is reported. |
|
proposition |
1..1 |
A possible fact, the validity of which is assessed and reported by the Statement. A Statement can put forth the proposition as being true, false, or uncertain, and may provide an assessment of the level of confidence/evidence supporting this claim. |
||
direction |
string |
0..1 |
A term indicating whether the Statement supports, disputes, or remains neutral w.r.t. the validity of the Proposition it evaluates. |
|
strength |
0..1 |
The strength of support that the Statement is determined to provide for or against the Variant Clinical Significance Proposition for the assessed variant, based on the curation and reporting conventions of the AMP/ASCO/CAP 2017 Guidelines. |
||
quality |
D | 0..1 |
A term used to report the quality of the assessment of a Proposition taking into consideration the reliability of the method, the contributor’s self-reporting of the rigor of the evaluation, and the overall robustness of the supporting or disputing evidence. This is useful when there is a consistent policy and authority that manages and a governing framework for evaluating the quality of evidence. Also known as trust rating, review status or ranking. |
|
score |
D | number |
0..1 |
A quantitative score that indicates the strength of a Proposition’s assessment in the direction indicated (i.e. how strongly supported or disputed the Proposition is believed to be). Depending on its implementation, a score may reflect how confident that agent is that the Proposition is true or false, or the strength of evidence they believe supports or disputes it. Instructions for how to interpret the meaning of a given score may be gleaned from the method or document referenced in ‘specifiedBy’ attribute. |
classification |
1..1 |
A single term or phrase classifying the subject variant based on the outcome of direction and strength assessments of the Statement’s Proposition, using terms from the AMP/ASCO/CAP 2017 Guidelines. |
||
hasEvidence |
⋮ | 0..m |
An individual piece of information that was evaluated as evidence in assessing the validity of the Proposition put forth by the Statement. |
|
hasEvidenceLines |
⋮ | 0..m |
An evidence-based argument that supports or disputes the validity of the proposition that a Statement assesses or puts forth as true. The strength and direction of this argument (whether it supports or disputes the proposition, and how strongly) is based on an interpretation of one or more pieces of information as evidence (i.e. ‘Evidence Items). |
Additional Constraints
If property… |
has value… |
then property… |
must… |
|---|---|---|---|
classification.primaryCoding.code |
tier i |
hasEvidenceLines |
be one of: iriReference, Variant Diagnostic Evidence Line (AAC 2017), Variant Prognostic Evidence Line (AAC 2017), Variant Therapeutic Evidence Line (AAC 2017) |
classification.primaryCoding.code |
tier i |
classification.name |
have value Tier I |
classification.primaryCoding.code |
tier i |
strength.primaryCoding.code |
have value strong |
classification.primaryCoding.code |
tier i |
direction |
have value supports |
classification.primaryCoding.code |
tier ii |
hasEvidenceLines |
be one of: iriReference, Variant Diagnostic Evidence Line (AAC 2017), Variant Prognostic Evidence Line (AAC 2017), Variant Therapeutic Evidence Line (AAC 2017) |
classification.primaryCoding.code |
tier ii |
classification.name |
have value Tier II |
classification.primaryCoding.code |
tier ii |
strength.primaryCoding.code |
have value potential |
classification.primaryCoding.code |
tier ii |
direction |
have value supports |
classification.primaryCoding.code |
tier iii |
classification.name |
have value Tier III |
classification.primaryCoding.code |
tier iii |
strength |
not be provided |
classification.primaryCoding.code |
tier iii |
direction |
have value neutral |
classification.primaryCoding.code |
tier iv |
classification.name |
have value Tier IV |
classification.primaryCoding.code |
tier iv |
strength |
not be provided |
classification.primaryCoding.code |
tier iv |
direction |
have value disputes |
Composes: Statement
Artifacts
Variant Amp/Asco/Cap Evidence Line (AAC 2017)
Draft
May change significantly in future releases. See Maturity Model.
Computational Definition
General statement for AMP/ASCO/CAP
Information Model
Field |
Flags |
Type |
Limits |
Description |
|---|---|---|---|---|
id |
string |
0..1 |
The ‘logical’ identifier of the Entity in the system of record, e.g. a UUID. This ‘id’ is unique within a given system, but may or may not be globally unique outside the system. It is used within a system to reference an object from another. |
|
type |
string |
1..1 |
MUST be “EvidenceLine”. |
|
name |
string |
0..1 |
A primary name for the entity. |
|
description |
string |
0..1 |
A free-text description of the Entity. |
|
aliases |
⋮ | string |
0..m |
Alternative name(s) for the Entity. |
extensions |
⋮ | 0..m |
A list of extensions to the Entity, that allow for capture of information not directly supported by elements defined in the model. |
|
specifiedBy |
0..1 |
A specification that describes all or part of the process that led to creation of the Information Entity |
||
contributions |
↓ | 0..m |
Specific actions taken by an Agent toward the creation, modification, validation, or deprecation of an Information Entity. |
|
reportedIn |
⋮ | 0..m |
A document in which the the Information Entity is reported. |
|
targetProposition |
Variant Prognostic Proposition | Variant Diagnostic Proposition | Variant Therapeutic Response Proposition | iriReference |
1..1 |
The possible fact against which evidence items contained in an Evidence Line were collectively evaluated, in determining the overall strength and direction of support they provide. For example, in an ACMG Guideline-based assessment of variant pathogenicity, the support provided by distinct lines of evidence are assessed against a target proposition that the variant is pathogenic for a specific disease. |
|
hasEvidenceItems |
⋮ | 0..m |
An individual piece of information that was evaluated as evidence in building the argument represented by an Evidence Line. |
|
directionOfEvidenceProvided |
string |
1..1 |
The direction of support that the Evidence Line is determined to provide toward its target Proposition (supports, disputes, neutral) |
|
strengthOfEvidenceProvided |
0..1 |
The strength of support that an Evidence Line is determined to provide for or against its target Proposition, evaluated relative to the direction indicated by the directionOfEvidenceProvided value. |
||
scoreOfEvidenceProvided |
number |
0..1 |
A quantitative score indicating the strength of support that an Evidence Line is determined to provide for or against its target Proposition, evaluated relative to the direction indicated by the directionOfEvidenceProvided value. |
|
evidenceOutcome |
0..1 |
A term summarizing the overall outcome of the evidence assessment represented by the Evidence Line, in terms of the direction and strength of support it provides for or against the target Proposition. |
Composes: Evidence Line
Used in: Variant Diagnostic Evidence Line (AAC 2017), Variant Prognostic Evidence Line (AAC 2017), Variant Therapeutic Evidence Line (AAC 2017)
Artifacts
Variant Diagnostic Evidence Line (AAC 2017)
Draft
May change significantly in future releases. See Maturity Model.
Computational Definition
Diagnostic statement for AMP/ASCO/CAP
Information Model
Field |
Flags |
Type |
Limits |
Description |
|---|---|---|---|---|
id |
string |
0..1 |
The ‘logical’ identifier of the Entity in the system of record, e.g. a UUID. This ‘id’ is unique within a given system, but may or may not be globally unique outside the system. It is used within a system to reference an object from another. |
|
type |
string |
1..1 |
MUST be “EvidenceLine”. |
|
name |
string |
0..1 |
A primary name for the entity. |
|
description |
string |
0..1 |
A free-text description of the Entity. |
|
aliases |
⋮ | string |
0..m |
Alternative name(s) for the Entity. |
extensions |
⋮ | 0..m |
A list of extensions to the Entity, that allow for capture of information not directly supported by elements defined in the model. |
|
specifiedBy |
0..1 |
A specification that describes all or part of the process that led to creation of the Information Entity |
||
contributions |
↓ | 0..m |
Specific actions taken by an Agent toward the creation, modification, validation, or deprecation of an Information Entity. |
|
reportedIn |
⋮ | 0..m |
A document in which the the Information Entity is reported. |
|
targetProposition |
1..1 |
The possible fact against which evidence items contained in an Evidence Line were collectively evaluated, in determining the overall strength and direction of support they provide. For example, in an ACMG Guideline-based assessment of variant pathogenicity, the support provided by distinct lines of evidence are assessed against a target proposition that the variant is pathogenic for a specific disease. |
||
hasEvidenceItems |
⋮ | 0..m |
An individual piece of information that was evaluated as evidence in building the argument represented by an Evidence Line. |
|
directionOfEvidenceProvided |
string |
1..1 |
The direction of support that the Evidence Line is determined to provide toward its target Proposition (supports, disputes, neutral) |
|
strengthOfEvidenceProvided |
0..1 |
The strength of support that an Evidence Line is determined to provide for or against its target Proposition, evaluated relative to the direction indicated by the directionOfEvidenceProvided value. |
||
scoreOfEvidenceProvided |
number |
0..1 |
A quantitative score indicating the strength of support that an Evidence Line is determined to provide for or against its target Proposition, evaluated relative to the direction indicated by the directionOfEvidenceProvided value. |
|
evidenceOutcome |
0..1 |
A term summarizing the overall outcome of the evidence assessment represented by the Evidence Line, in terms of the direction and strength of support it provides for or against the target Proposition. |
Composes: Variant Amp/Asco/Cap Evidence Line (AAC 2017)
Used in: Variant Clinical Significance Statement (AAC 2017)
Artifacts
Variant Prognostic Evidence Line (AAC 2017)
Draft
May change significantly in future releases. See Maturity Model.
Computational Definition
Prognostic statement for AMP/ASCO/CAP
Information Model
Field |
Flags |
Type |
Limits |
Description |
|---|---|---|---|---|
id |
string |
0..1 |
The ‘logical’ identifier of the Entity in the system of record, e.g. a UUID. This ‘id’ is unique within a given system, but may or may not be globally unique outside the system. It is used within a system to reference an object from another. |
|
type |
string |
1..1 |
MUST be “EvidenceLine”. |
|
name |
string |
0..1 |
A primary name for the entity. |
|
description |
string |
0..1 |
A free-text description of the Entity. |
|
aliases |
⋮ | string |
0..m |
Alternative name(s) for the Entity. |
extensions |
⋮ | 0..m |
A list of extensions to the Entity, that allow for capture of information not directly supported by elements defined in the model. |
|
specifiedBy |
0..1 |
A specification that describes all or part of the process that led to creation of the Information Entity |
||
contributions |
↓ | 0..m |
Specific actions taken by an Agent toward the creation, modification, validation, or deprecation of an Information Entity. |
|
reportedIn |
⋮ | 0..m |
A document in which the the Information Entity is reported. |
|
targetProposition |
1..1 |
The possible fact against which evidence items contained in an Evidence Line were collectively evaluated, in determining the overall strength and direction of support they provide. For example, in an ACMG Guideline-based assessment of variant pathogenicity, the support provided by distinct lines of evidence are assessed against a target proposition that the variant is pathogenic for a specific disease. |
||
hasEvidenceItems |
⋮ | 0..m |
An individual piece of information that was evaluated as evidence in building the argument represented by an Evidence Line. |
|
directionOfEvidenceProvided |
string |
1..1 |
The direction of support that the Evidence Line is determined to provide toward its target Proposition (supports, disputes, neutral) |
|
strengthOfEvidenceProvided |
0..1 |
The strength of support that an Evidence Line is determined to provide for or against its target Proposition, evaluated relative to the direction indicated by the directionOfEvidenceProvided value. |
||
scoreOfEvidenceProvided |
number |
0..1 |
A quantitative score indicating the strength of support that an Evidence Line is determined to provide for or against its target Proposition, evaluated relative to the direction indicated by the directionOfEvidenceProvided value. |
|
evidenceOutcome |
0..1 |
A term summarizing the overall outcome of the evidence assessment represented by the Evidence Line, in terms of the direction and strength of support it provides for or against the target Proposition. |
Composes: Variant Amp/Asco/Cap Evidence Line (AAC 2017)
Used in: Variant Clinical Significance Statement (AAC 2017)
Artifacts
Variant Therapeutic Evidence Line (AAC 2017)
Draft
May change significantly in future releases. See Maturity Model.
Computational Definition
Therapeutic statement for AMP/ASCO/CAP
Information Model
Field |
Flags |
Type |
Limits |
Description |
|---|---|---|---|---|
id |
string |
0..1 |
The ‘logical’ identifier of the Entity in the system of record, e.g. a UUID. This ‘id’ is unique within a given system, but may or may not be globally unique outside the system. It is used within a system to reference an object from another. |
|
type |
string |
1..1 |
MUST be “EvidenceLine”. |
|
name |
string |
0..1 |
A primary name for the entity. |
|
description |
string |
0..1 |
A free-text description of the Entity. |
|
aliases |
⋮ | string |
0..m |
Alternative name(s) for the Entity. |
extensions |
⋮ | 0..m |
A list of extensions to the Entity, that allow for capture of information not directly supported by elements defined in the model. |
|
specifiedBy |
0..1 |
A specification that describes all or part of the process that led to creation of the Information Entity |
||
contributions |
↓ | 0..m |
Specific actions taken by an Agent toward the creation, modification, validation, or deprecation of an Information Entity. |
|
reportedIn |
⋮ | 0..m |
A document in which the the Information Entity is reported. |
|
targetProposition |
1..1 |
The possible fact against which evidence items contained in an Evidence Line were collectively evaluated, in determining the overall strength and direction of support they provide. For example, in an ACMG Guideline-based assessment of variant pathogenicity, the support provided by distinct lines of evidence are assessed against a target proposition that the variant is pathogenic for a specific disease. |
||
hasEvidenceItems |
⋮ | 0..m |
An individual piece of information that was evaluated as evidence in building the argument represented by an Evidence Line. |
|
directionOfEvidenceProvided |
string |
1..1 |
The direction of support that the Evidence Line is determined to provide toward its target Proposition (supports, disputes, neutral) |
|
strengthOfEvidenceProvided |
0..1 |
The strength of support that an Evidence Line is determined to provide for or against its target Proposition, evaluated relative to the direction indicated by the directionOfEvidenceProvided value. |
||
scoreOfEvidenceProvided |
number |
0..1 |
A quantitative score indicating the strength of support that an Evidence Line is determined to provide for or against its target Proposition, evaluated relative to the direction indicated by the directionOfEvidenceProvided value. |
|
evidenceOutcome |
0..1 |
A term summarizing the overall outcome of the evidence assessment represented by the Evidence Line, in terms of the direction and strength of support it provides for or against the target Proposition. |
Composes: Variant Amp/Asco/Cap Evidence Line (AAC 2017)
Used in: Variant Clinical Significance Statement (AAC 2017)
Artifacts